Literature DB >> 22320795

Three-dimensional lung tumor segmentation from x-ray computed tomography using sparse field active models.

Joseph Awad1, Amir Owrangi, Lauren Villemaire, Elaine O'Riordan, Grace Parraga, Aaron Fenster.   

Abstract

PURPOSE: Manual segmentation of lung tumors is observer dependent and time-consuming but an important component of radiology and radiation oncology workflow. The objective of this study was to generate an automated lung tumor measurement tool for segmentation of pulmonary metastatic tumors from x-ray computed tomography (CT) images to improve reproducibility and decrease the time required to segment tumor boundaries.
METHODS: The authors developed an automated lung tumor segmentation algorithm for volumetric image analysis of chest CT images using shape constrained Otsu multithresholding (SCOMT) and sparse field active surface (SFAS) algorithms. The observer was required to select the tumor center and the SCOMT algorithm subsequently created an initial surface that was deformed using level set SFAS to minimize the total energy consisting of mean separation, edge, partial volume, rolling, distribution, background, shape, volume, smoothness, and curvature energies.
RESULTS: The proposed segmentation algorithm was compared to manual segmentation whereby 21 tumors were evaluated using one-dimensional (1D) response evaluation criteria in solid tumors (RECIST), two-dimensional (2D) World Health Organization (WHO), and 3D volume measurements. Linear regression goodness-of-fit measures (r(2) = 0.63, p < 0.0001; r(2) = 0.87, p < 0.0001; and r(2) = 0.96, p < 0.0001), and Pearson correlation coefficients (r = 0.79, p < 0.0001; r = 0.93, p < 0.0001; and r = 0.98, p < 0.0001) for 1D, 2D, and 3D measurements, respectively, showed significant correlations between manual and algorithm results. Intra-observer intraclass correlation coefficients (ICC) demonstrated high reproducibility for algorithm (0.989-0.995, 0.996-0.997, and 0.999-0.999) and manual measurements (0.975-0.993, 0.985-0.993, and 0.980-0.992) for 1D, 2D, and 3D measurements, respectively. The intra-observer coefficient of variation (CV%) was low for algorithm (3.09%-4.67%, 4.85%-5.84%, and 5.65%-5.88%) and manual observers (4.20%-6.61%, 8.14%-9.57%, and 14.57%-21.61%) for 1D, 2D, and 3D measurements, respectively.
CONCLUSIONS: The authors developed an automated segmentation algorithm requiring only that the operator select the tumor to measure pulmonary metastatic tumors in 1D, 2D, and 3D. Algorithm and manual measurements were significantly correlated. Since the algorithm segmentation involves selection of a single seed point, it resulted in reduced intra-observer variability and decreased time, for making the measurements.

Entities:  

Mesh:

Year:  2012        PMID: 22320795     DOI: 10.1118/1.3676687

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  4 in total

1.  Radiology and Enterprise Medical Imaging Extensions (REMIX).

Authors:  Barbaros S Erdal; Luciano M Prevedello; Songyue Qian; Mutlu Demirer; Kevin Little; John Ryu; Thomas O'Donnell; Richard D White
Journal:  J Digit Imaging       Date:  2018-02       Impact factor: 4.056

2.  2D-3D radiograph to cone-beam computed tomography (CBCT) registration for C-arm image-guided robotic surgery.

Authors:  Wen Pei Liu; Yoshito Otake; Mahdi Azizian; Oliver J Wagner; Jonathan M Sorger; Mehran Armand; Russell H Taylor
Journal:  Int J Comput Assist Radiol Surg       Date:  2014-12-12       Impact factor: 2.924

3.  Automatic lung tumor segmentation with leaks removal in follow-up CT studies.

Authors:  R Vivanti; L Joskowicz; O A Karaaslan; J Sosna
Journal:  Int J Comput Assist Radiol Surg       Date:  2015-01-22       Impact factor: 2.924

4.  Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes in a phase II clinical trial.

Authors:  M Catherine Pietanza; Ethan M Basch; Alex Lash; Lawrence H Schwartz; Michelle S Ginsberg; Binsheng Zhao; Marwan Shouery; Mary Shaw; Lauren J Rogak; Manda Wilson; Aaron Gabow; Marcia Latif; Kai-Hsiung Lin; Qinfei Wu; Samantha L Kass; Claire P Miller; Leslie Tyson; Dyana K Sumner; Alison Berkowitz-Hergianto; Camelia S Sima; Mark G Kris
Journal:  J Clin Oncol       Date:  2013-04-29       Impact factor: 44.544

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.